External Certifications
Certified BreederHealth Testing: Polyneuropathy, Greyhound Type (NDRG1), GM2 Gangliosidosis, Poodle Type, GM1 Gangliosidosis, Portuguese Water Dog Type, GM1 Gangliosidosis, Alaskan Husky Type, Glycogen Storage Disease Type VII, GSD VII, Glycogen Storage Disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM Wachtelhund Variant), Glycogen Storage Disease Type IIIA, GSD IIIA, Glycogen Storage Disease Ia, Glaucoma (BCG), Border Collie Type, Glanzmann's Thrombasthenia, Otterhound Type, Glanzmann's Thrombasthenia, Great Pyrenees Type, Gall Bladder Mucocele Formation (Shetland Sheepdog Type), Fucosidosis, Familial Nephropathy, English Springer Spaniel Type, Familial Nephropathy, Cocker Spaniel Type, Factor XI Deficiency, Lagotto Storage Disease (LSD), L-2-Hydroxyglutaric Aciduria (L2HGA), Staffordshire Bull Terrier Type, Juvenile Myoclonic Epilepsy (JME), Juvenile Laryngeal Paralysis & Polyneuropathy (JLPP), Intestinal Cobalamin Malabsorption (IGS CUBN Exon 8), Border Collie Type, Inherited Myopathy in Great Danes (IMGD), Ichthyosis, Great Dane Type, Ichthyosis, Golden Retriever Type 1, Ichthyosis, American Bulldog Type, Hypomyelination, Weimaraner Type, Hereditary Nephritis, Samoyed Type, Hereditary Nasal Parakeratosis (HNPK), Hereditary (Juvenile) Cataracts (HC; JC), Narcolepsy, Doberman Pinscher Type, Narcolepsy, Dachshund Type, Myotubular Myopathy 1, Rottweiler Type, Musladin-Leuke Syndrome (MLS), Muscular Dystrophy, Ullrich-type; mutation originally found in Landseer, Multifocal Retinopathy 3 (CMR3), Multifocal Retinopathy 1 (CMR1), Coton de Tulear Type, Mucopolysaccharidosis VII (MPS VII GUSB), Shepherd Type, Mucopolysaccharidosis IIIA (MPS IIIA), New Zealand Huntaway Type, Mucopolysaccharidosis IIIA (MPS IIIA), Dachshund Type, Mucopolysaccharidosis Type I (MPS I), Macular Corneal Dystrophy, MCD (CHST6), Lundehund Syndrome, Ligneous Membranitis, LM (PLG), Leukocyte Adhesion Deficiency, Type III, Lethal Acrodermatitis (LAD), Bull Terrier Type, Late Onset Ataxia, Spinocerebellar Ataxia (LOA, SCA), Osteogenesis Imperfecta (OI), Golden Retriever Type, Osteogenesis Imperfecta (OI), Beagle Type, Osteochondrodysplasia, Miniature Poodle Type, Oculocutaneous Albinism (Small Breed Type), Oculocutaneous Albinism, Neuronal Ceroid Lipofuscinosis 8 (NCL8), Setter Type, Neuronal Ceroid Lipofuscinosis 7 (NCL7), Neuronal Ceroid Lipofuscinosis 5 (NCL5), Golden Retriever Type, Neuronal Ceroid Lipofuscinosis 5 (NCL5), Border Collie Type, Neuronal Ceroid Lipofuscinosis 4A (NCL4A), American Staffordshire Terrier Type, Neuronal Ceroid Lipofuscinosis 2 (NCL2), Neuronal Ceroid Lipofuscinosis 12 (NCL12), Australian Cattle Dog Type, Neuronal Ceroid Lipofuscinosis 10 (NCL10), American Bulldog Type, Neuronal Ceroid Lipofuscinosis 1 (NCL1), Cane Corso Type, Neuroaxonal Dystrophy (NAD), Spanish Water Dog Type, Neuroaxonal Dystrophy (NAD), Rottweiler Type, Neonatal Encephalopathy with Seizures (NEwS), Neonatal Cortical Cerebellar Degeneration (NCCD), Narcolepsy, Labrador Retriever Type, PRA, Cone-Rod Dystrophy 1 (PRA-crd1), PRA, Shetland Sheepdog Type, PRA, Irish Setter Type, PRA, Giant Schnauzer Type, PRA, Basenji Type, Primary Open Angle Glaucoma and Primary Lens Luxation (POAG/PLL), Shar-Pei Type, Primary Open Angle Glaucoma, Basset Hound Type, Primary Lens Luxation (PLL), Primary Hyperoxaluria, Primary Ciliary Dyskinesia, Kartagner Syndrome (PCD), Polyneuropathy with Ocular Abnormalities and Neuronal Vacuolation, Polyneuropathy 2, Leonberger and Saint Bernard Type, Polyneuropathy 1, Leonberger and Saint Bernard Type, Persistent Müllerian Duct Syndrome, Duchenne Muscular Dystrophy, Pembroke Welsh Corgi Type, P2RY12 Receptor Platelet Disorder, Retinal Dysplasia/Oculoskeletal Dysplasia 2, Retinal Dysplasia/Oculoskeletal Dysplasia 1 (RD OSD), Renal Cystadenocarcinoma and Nodular Dermatofibrosis (RCND), Recurrent Inflammatory Pulmonary (Collie Type) - Single Assay Test, Pyruvate Kinase Deficiency (PKD), Terrier Type, Pyruvate Kinase Deficiency (PKD), Pug Type, Pyruvate Kinase Deficiency (PKD), Labrador Retriever Type, Pyruvate Kinase Deficiency (PKD), Beagle Type, Pyruvate Kinase Deficiency, Basenji Type (PKD), Pyruvate Dehydrogenase Phosphatase 1 Deficiency (PDP1), Protein-Losing Nephropathy (PLN; NPHS1 Gene Variant), PRA, Rod-Cone Dysplasia 4 (rcd4), PRA, Rod-Cone Dysplasia 3 (rcd3), PRA (PRA1), Papillon Type, PRA, Golden Retriever 2, PRA, Golden Retriever 1, PRA, Cone-Rod Dystrophy 4 (PRA-crd4), PRA, Cone-Rod Dystrophy 2 (PRA-crd2), Progressive Retinal Atrophy (PRA), Generalized, von Willebrand Disease III (vWD III), Shetland Sheepdog Type, von Willebrand Disease III (vWD III), Scottish Terrier Type, von Willebrand Disease III (vWD III), Kooikerhondje Type, von Willebrand Disease II (vWD II), Van Den Ende-Gupta Syndrome (VDEGS), Trapped Neutrophil Syndrome, Cohen Syndrome (TNS), Thrombopathia, Newfoundland Type, Thrombopathia, Basset Hound Type, Thrombopathia, American Eskimo Dog Type, Stargardt Disease, Spondylocostal Dysostosis, Skeletal Dysplasia (SD2), Shar-Pei Autoinflammatory Disease, Severe Combined Immunodeficiency Disease, X-Linked (XSCID), Corgi Type, Severe Combined Immunodeficiency Disease, Terrier Type, Sensory Neuropathy, Border Collie Type (SN), Cystinuria Type 1, Newfoundland (PennGen), Cystinuria Type II-B, Miniature Pinscher Type, Cystinuria Type II-A, Australian Cattle Dog Type, Cystinuria Type 1A, Labrador Retriever Type, Cyclic Neutropenia, Grey Collie Syndrome (CN), Congenital Stationary Night Blindness (CSNB), Congenital Myasthenic Syndrome (CMS), Old Danish Pointer Type, Congenital Myasthenic Syndrome (CMS), Labrador Retriever Type, Congenital Myasthenic Syndrome (CMS), Jack Russell Terrier Type, Congenital Hypothyroidism with Goiter, Terrier Type (CHG), Cone Degeneration, Labrador Retriever Type, Cone Degeneration, German Shorthaired Pointer Type, Cone Degeneration, German Shepherd Dog Type, Compliment 3 Deficiency (C3), Cleft Palate (ADAMTS20), Chondrodystrophy, Norwegian Elkhound and Karelian Bear Dog Variant (ITGA10), Cerebellar Degeneration, Cerebellar Cortical Degeneration (CCD), Cerebellar Ataxia, Finnish Hound Type, Episodic Falling Syndrome (EFS), Epidermolytic Hyperkeratosis, Elliptocytosis, Ehlers-Danlos Syndrome, Ectodermal Dysplasia, X-Linked (Shepherd Type), Ectodermal Dysplasia, X-Linked (Dachshund Type), Ectodermal Dysplasia, Chesapeake Bay Retriever Type, Early Retinal Degeneration, Dystrophic Epidermolysis Bullosa, Dilated Cardiomyopathy 2 (DCM2), Dilated Cardiomyopathy 1 (DCM1), Cystic Renal Dysplasia and Hepatic Fibrosis, Dental Hypomineralization (DH), Degenerative Myelopathy Early-Onset Risk Modifier, Pembroke Welsh Corgi Type, Dandy-Walker-like Malformation (DWLM), Eurasier Type, Cystinuria Type 3 (Variant 3), Bulldog Type Risk Factor, Cystinuria Type 3 (Variant 1 & 2), Bulldog Type Risk Factor, Canine Scott Syndrome (CSS), Canine Multiple System Degeneration, Kerry Blue Terrier Type, Canine Multiple System Degeneration (Chinese Crested Type), Benign Familial Juvenile Epilepsy (BFJE), Amelogenesis Imperfecta (AI), Akita Type, Adult Paroxysmal Dyskinesia, Acute Respiratory Distress Syndrome, Dalmatian Type, Acral Mutilation Syndrome (AMS), Chondrodysplasia/Dwarfism, Brachycephaly, von Willebrand Disease I (vWD I), PRA, Rod-Cone Degeneration (PRA-prcd), Neuronal Ceroid Lipofuscinosis 8 (NCL8), Australian Shepherd Type, Neuronal Ceroid Lipofuscinosis 6 (NCL 6), Multifocal Retinopathy 1 (CMR1), Multiple Drug Sensitivity (MDR1), Intestinal Cobalamin Malabsorption (IGS CUBN Exon 53), Border Collie Type, Chondrodystrophy and IVDD Risk (CDDY-IVDD), Hyperuricosuria (HUU), Hereditary (Juvenile) Cataracts (HC; JC), Australian Shepherd Type, Exercise Induced Collapse (EIC), Degenerative Myelopathy (DM; SOD1B), Bernese Mountain Dog Type, Craniomandibular Osteopathy (CMO), Cone Degeneration, Collie Eye Anomaly (CEA)